‘Remarkable’ bowel cancer drug can rid patients FULLY of disease – and works in 100% of people [Video]

AN immunotherapy drug could spare bowel cancer patients the need for surgery and chemotherapy after results showed it was effective in 100 per cent of cases.

Jemperli, also called dostarlimab, showed “unprecedented results”, maker GSK said, with no evidence of disease in all patients treated.

Everyone on the medication had locally advanced mismatch repair deficient (dMMR) rectal cancer, a form of bowel cancer, according to data presented at the American Society of Clinical Oncology (ASCO) conference in Chicago.

Jemperli is already approved on the NHS for women with some types of advanced or recurrent womb cancer.

The data showed all 42 patients in a trial led by Memorial Sloan Kettering Cancer Centre in the US had a complete response to treatment, with no evidence of tumours on scans.

The first 24 patients have been followed up so …